PH31452A - Pharmaceutical composition. - Google Patents

Pharmaceutical composition.

Info

Publication number
PH31452A
PH31452A PH51217A PH51217A PH31452A PH 31452 A PH31452 A PH 31452A PH 51217 A PH51217 A PH 51217A PH 51217 A PH51217 A PH 51217A PH 31452 A PH31452 A PH 31452A
Authority
PH
Philippines
Prior art keywords
nizatidine
nitro
iii
ethenediamine
contg
Prior art date
Application number
PH51217A
Other languages
English (en)
Inventor
Usmccauley Mary Kay
Moder Kenneth Philip
Speakman Jeffrey Lynn
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH31452A publication Critical patent/PH31452A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
PH51217A 1994-08-30 1995-08-30 Pharmaceutical composition. PH31452A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/298,486 US5470865A (en) 1994-08-30 1994-08-30 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
PH31452A true PH31452A (en) 1998-11-03

Family

ID=23150736

Family Applications (1)

Application Number Title Priority Date Filing Date
PH51217A PH31452A (en) 1994-08-30 1995-08-30 Pharmaceutical composition.

Country Status (24)

Country Link
US (1) US5470865A (es)
EP (1) EP0704214B1 (es)
JP (1) JPH0892087A (es)
KR (1) KR960006921A (es)
CN (1) CN1127635A (es)
AT (1) ATE192039T1 (es)
AU (1) AU700488B2 (es)
BR (1) BR9503832A (es)
CA (1) CA2157240A1 (es)
CO (1) CO4410183A1 (es)
CZ (1) CZ189395A3 (es)
DE (1) DE69516475T2 (es)
ES (1) ES2145221T3 (es)
FI (1) FI954050L (es)
HU (1) HUT72672A (es)
IL (1) IL115012A0 (es)
NO (1) NO952825L (es)
NZ (1) NZ272833A (es)
PE (1) PE33696A1 (es)
PH (1) PH31452A (es)
PL (1) PL310207A1 (es)
TR (1) TR199500885A2 (es)
YU (1) YU57495A (es)
ZA (1) ZA957281B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4828678B2 (ja) * 1998-11-18 2011-11-30 武田薬品工業株式会社 圧縮成形物
KR20010068707A (ko) * 2000-01-07 2001-07-23 최용준 시계줄
JP2001240534A (ja) * 2000-02-29 2001-09-04 Bio Kagaku Kk 液状組成物
KR102178793B1 (ko) * 2019-04-17 2020-11-13 황용석 순금 장식연결구

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
HU190527B (en) * 1983-02-07 1986-09-29 Eli Lilly And Co,Us Process for preparing thiazole derivatives
EP0230127A1 (en) * 1985-12-18 1987-07-29 Eli Lilly And Company Synthesis of nizatidine
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
US4857344A (en) 1986-12-31 1989-08-15 Del Monte Corporation Method for treating pineapple to inhibit browning
ATE86619T1 (de) * 1987-04-06 1993-03-15 Heumann Pharma Gmbh & Co Verfahren zur herstellung von nitroethenderivaten.
EP0396830B1 (en) * 1989-05-10 1993-10-27 Council of Scientific and Industrial Research An improved process for the preparation of 1-substituted amino-1-substituted thio-2-nitro alkenes
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
US5334725A (en) * 1991-05-21 1994-08-02 Eli Lilly And Company 2-aminomethyl-4-exomethylenethiazoline epoxides
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same

Also Published As

Publication number Publication date
EP0704214B1 (en) 2000-04-26
IL115012A0 (en) 1996-01-31
NO952825L (no) 1996-03-01
ZA957281B (en) 1997-02-28
DE69516475D1 (de) 2000-05-31
PL310207A1 (en) 1996-03-04
ES2145221T3 (es) 2000-07-01
HUT72672A (en) 1996-05-28
PE33696A1 (es) 1996-08-29
AU3033495A (en) 1996-03-14
EP0704214A1 (en) 1996-04-03
BR9503832A (pt) 1996-09-10
CO4410183A1 (es) 1997-01-09
NO952825D0 (no) 1995-07-17
FI954050A7 (fi) 1996-03-02
DE69516475T2 (de) 2000-09-28
FI954050L (fi) 1996-03-02
YU57495A (sh) 1999-07-28
JPH0892087A (ja) 1996-04-09
ATE192039T1 (de) 2000-05-15
TR199500885A2 (tr) 1996-06-21
CN1127635A (zh) 1996-07-31
HU9502542D0 (en) 1995-10-30
US5470865A (en) 1995-11-28
KR960006921A (ko) 1996-03-22
NZ272833A (en) 1997-04-24
CZ189395A3 (en) 1996-03-13
AU700488B2 (en) 1999-01-07
FI954050A0 (fi) 1995-08-29
CA2157240A1 (en) 1996-03-01

Similar Documents

Publication Publication Date Title
IL57262A (en) Method and composition for reducing herbicidal injuries to sorghum and rice plants using 2,4-disubstituted-5-thiazole-carboxylic acids and derivatives and some novel compounds of this type
PT75210B (en) A method of minimizing water loss from a water-containing topical preparation and a process for preparing said preparation
CS38989A2 (en) Method of phenoxyacetamidoderivative production
JPS53129262A (en) Method of surface treatment
PH31452A (en) Pharmaceutical composition.
DE3850778D1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
FI830754A7 (fi) Menetelmä 1- substituoitujen N-(8 - ergolinyyli)-N',N'-dietyyliureoiden valmistamiseksi.
DE69521200D1 (de) Formulierung von energie
JPS53107476A (en) Cultivation medium for and culturing of basidiomycetes
JPS5636419A (en) Medical treating agent for skin
FI954749A0 (fi) Uusi menetelmä klonidiinijohdannaisten valmistamiseksi
PH19228A (en) N-(2-(((5-dimethylamino)-methyl-2-furanyl)-methyl)-thio)-ethyl)-n'(3,4-methylenedioxybenzyl)-2-nitro-1,1-ethenediamine,process for the preparation thereof and pharmaceutical composition thereof
NZ191699A (en) N-(1-methyl-2-pyrrolidinyl methyl)-2,3-dimethoxy-5-methyl-sulphamoyl benzamide derivatives pharmaceutical compositions
DK0796256T3 (da) Fremgangsmåde til fremstilling af ranitidin
ATE17083T1 (de) Entgiftetes nervengift aus e-coli, verfahren zu dessen herstellung und dasselbe enthaltende immunologische zusammensetzungen.
ZA808014B (en) N-(3-(1'-3"-oxapentamethyleneamino-ethylideneamino)-2,4,6-triiodobenzoyl)- -amino -methylpropionitrile
JPS5526881A (en) Semisynthesis of insulin
FR2618335B1 (fr) Extrait de cochlospermum planchonii, procede de preparation et utilisation therapeutique
SE9000658D0 (sv) Mittel zur behandlung der schlaf-apnoe
JPS51115193A (en) Preparation of straw matting for wine cask
DE3576498D1 (de) 2-sulfamoyl-1h-indole-derivate zur behandlung von hohem intraocularem druck.
JPS55113719A (en) Immunity enhancer
FI972528L (fi) Menetelmä N-(4-(5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli)-3-metoksibentsoyyli)-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi
IT1169237B (it) Metodo per l'isolamento e la purificazione della n-(2-(((5-(dimetilamino)-metil-2-furanil)-metil)-tio)-etil)-n'-metil-2-nitro-1,1-etendiamina
FI882979L (fi) Mikrobiologinen menetelmä 4'-13(S)-dihydro-4'-jodidoksorubisiinin valmistamiseksi